Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -W-
11.11.2024 16:00:11

EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

11.11.2024 / 16:00 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: December 12, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: December 12, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

Report Type: Annual financial report of the group

Language: German
Date of disclosure: December 12, 2024
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: December 12, 2024
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: May 15, 2025
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: May 15, 2025
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/


11.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

2027149  11.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2027149&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu SCHOTT Pharmamehr Analysen

11.09.24 SCHOTT Pharma Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.09.24 SCHOTT Pharma Equal Weight Barclays Capital
02.09.24 SCHOTT Pharma Hold Jefferies & Company Inc.
02.09.24 SCHOTT Pharma Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
30.08.24 SCHOTT Pharma Neutral UBS AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

SCHOTT Pharma 26,18 -0,23% SCHOTT Pharma